The article discusses the possible effect of factor XI deficiency on the thrombosis risk of patients with hemophilia A and B. Topics covered include the effect of the factor on the bleeding risk of patients. Also mentioned is the development of factor XI concentrates by LFB Biomedicaments and BioProducts Laboratory.